NKF KDOQI GUIDELINES

KDOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure

D. REFERENCES (ADULT GUIDELINES)

Note: Asterisks indicate the citations that were used in the structured review of the literature.

  1. Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A: Completeness of reporting of trials published in languages other than English: Implications for conduct and reporting of systematic reviews. Lancet 347:363-366, 1996
  2. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G: Language bias in randomised controlled trials published in English and German. Lancet 350:326-329, 1997
  3. Laupacis A, Wells G, Richardson WS, Tugwell P: Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 272:234-237, 1994
  4. Jaeschke R, Guyatt G, Sackett DL: Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 271:389-391, 1994
  5. Jaeschke R, Guyatt GH, Sackett DL: Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271:703-707, 1994
  6. Guyatt GH, Sackett DL, Cook DJ: Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 270:2598-2601, 1993
  7. Guyatt GH, Sackett DL, Cook DJ: Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 271:59-63, 1994
  8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
  9. Khan KS, Daya S, Jadad A: The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med 156:661-666, 1996
  10. Jadad AR, Rennie D: The randomized controlled trial gets a middle-aged checkup JAMA 279:319-320, 1998
  11. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S: Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists. Control Clin Trials 16:62-73, 1995
  12. Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412, 1995
  13. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE: A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 2:53-63, 1986
  14. *Lowrie EG, Huang WH, Lew NL: Death risk predictors among peritoneal dialysis and hemodialysis patients: A preliminary comparison. Am J Kidney Dis 26:220-228, 1995
  15. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31:997-1006, 1998
  16. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 7:198-207, 1996
  17. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, Shen FH, Gandhi VC, Tucker CT, Curtis FK, Coburn JW: Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 33:1567-1585, 1980
  18. Ahmed KR, Kopple JD: Nutrition in maintenance hemodialysis patients, in Kopple JD, Massry SG (eds): Nutritional Management of Renal Disease. Baltimore, MD, Williams and Wilkins, 1998, pp 563-600
  19. *Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 3:1613-1622, 1993
  20. Barrett BJ, Parfrey PS, Morgan J, Barre P, Fine A, Goldstein MB, Handa SP, Jindal KK, Kjellstrand CM, Levin A, Mandin H, Muirhead N, Richardson RM: Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 29:214-222, 1997
  21. *Marcen R, Teruel JL, de la Cal MA, Gamez C: The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis. Nephrol Dial Transplant 12:2324-2331, 1997
  22. *Soucie JM, McClellan WM: Early death in dialysis patients: Risk factors and impact on incidence and mortality rates. J Am Soc Nephrol 7:2169-2175, 1996
  23. *Iseki K, Uehara H, Nishime K, Tokuyama K, Yoshihara K, Kinjo K, Shiohira Y, Fukiyama K: Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. Am J Kidney Dis 28:541-548, 1996
  24. *Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736, 1996
  25. *Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P: Markers for survival in dialysis: A seven-year prospective study. Am J Kidney Dis 26:209-219, 1995
  26. Klang B, Bjorvell H, Cronqvist A: Patients with chronic renal failure and their ability to cope. Scand J Caring Sci 10:89-95; 1996
  27. *Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993
  28. Keys A, Brozek J, Henschel A, Mickelsen O, Taylor HL: The Biology of Human Starvation. Minneapolis, MN, University of Minnesota, 1950
  29. *Jones CH, Newstead CG, Will EJ, Smye SW, Davison AM: Assessment of nutritional status in CAPD patients: Serum albumin is not a useful measure. Nephrol Dial Transplant 12:1406-1413, 1997
  30. *Harty JC, Boulton H, Curwell J, Heelis N, Uttley L, Venning MC, Gokal R: The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 45:103-109, 1994
  31. *Jacob V, Marchant PR, Wild G, Brown CB, Moorhead PJ, el Nahas AM: Nutritional profile of continuous ambulatory peritoneal dialysis patients. Nephron 71:16-22, 1995
  32. *Oksa H, Ahonen K, Pasternack A, Marnela KM: Malnutrition in hemodialysis patients. Scand J Urol Nephrol 25:157-161, 1991
  33. *Han DS, Lee SW, Kang SW, Choi KH, Lee HY, Cho EY, Lee JH: Factors affecting low values of serum albumin in CAPD patients. Adv Perit Dial 12:288-292, 1996
  34. Kaysen GA, Stevenson FT, Depner TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658-668, 1997
  35. Kaysen GA, Rathore V, Shearer GC, Depner TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 48:510-516, 1995
  36. Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 95:39-45, 1995
  37. Docci D, Bilancioni R, Baldrati L, Capponcini C, Turci F, Feletti C: Elevated acute phase reactants in hemodialysis patients. Clin Nephrol 34:88-91, 1990
  38. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454, 1999
  39. Lindgren SC, Laurell CB, Sterner GN: Plasma protein homeostasis in chronic hemodialysis patients. Scand J Urol Nephrol 26:279-282, 1992
  40. Tuten MB, Wogt S, Dasse F, Leider Z: Utilization of prealbumin as a nutritional parameter. J Parenter Enteral Nutr 9:709-711, 1985
  41. *Goldwasser P, Michel MA, Collier J, Mittman N, Fein PA, Gusik SA, Avram MM: Prealbumin and lipoprotein(a) in hemodialysis: Relationships with patient and vascular access survival. Am J Kidney Dis 22:215-225, 1993
  42. Cano N, Di Costanzo-Dufetel J, Calaf R, Durbec JP, Lacombe P, Pascal S, Stroumza P, Labastle-Coeyrehourcq J: Prealbumin-retinol-binding-protein-retinol complex in hemodialysis patients. Am J Clin Nutr 47:664-667, 1988
  43. Sreedhara R, Avram MM, Blanco M, Batish R, Mittman N: Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 28:937-942, 1996
  44. Ingenbleek Y, Carpentier YA: A prognostic inflammatory and nutritional index scoring critically ill patients. IntJ Vitam Nutr Res 55:91-101, 1985
  45. *Avram MM, Goldwasser P, Erroa M, Fein PA: Predictors of survival in continuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 23:91-98, 1994
  46. Borovnicar DJ, Wong KC, Kerr PG, Stroud DB, Xiong DW, Strauss BJ, Atkins RC: Total body protein status assessed by different estimates of fat-free mass in adult peritoneal dialysis patients. Eur J Clin Nutr 50:607-616, 1996
  47. Keshaviah P: Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 4:1475-1485, 1994
  48. Piccoli GB, Quarello F, Salomone M, Iadarola GM, Funaro L, Marciello A, Fidelio T, Ghezzi PM, Cavalli PL, Vercellone A, Piccoli G: Are serum albumin and cholesterol reliable outcome markers in elderly dialysis patients? Nephrol Dial Transplant 10:S72-S77, 1995 (suppl 6)
  49. Bhatla B, Moore H, Emerson P, Keshaviah P, Prowant B, Nolph KD, Singh A: Lean body mass estimation by creatinine kinetics, bioimpedance, and dual energy x-ray absorptiometry in patients on continuous ambulatory peritoneal dialysis. ASAIO J 41:M442-M446, 1995
  50. *Oksa H, Pasternack A, Pasanen M: Serum urea-creatinine ratio as a prognostic index in hemodialysis patients. Clin Nephrol 27:125-130, 1987
  51. *Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31:103-110, 1982
  52. *De Lima J, Sesso R, Abensur H, Lopes HF, Giorgi MC, Krieger EM, Pileggi F: Predictors of mortality in long-term haemodialysis patients with a low prevalence of comorbid conditions. Nephrol Dial Transplant 10:1708-1713, 1995
  53. *Avram MM, Fein PA, Bonomini L, Mittman N, Loutoby R, Avram DK, Chattopadhyay J: Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five-year prospective study. Perit Dial Int 16:S190-S194, 1996 (suppl 1)
  54. *Canaud B, Garred LJ, Argiles A, Flavier JL, Bouloux C, Mion C: Creatinine kinetic modelling: A simple and reliable tool for the assessment of protein nutritional status in haemodialysis patients. Nephrol Dial Transplant 10:1405-1410, 1995
  55. *Husebye DG, Westlie L, Styrvoky TJ, Kjellstrand CM: Psychological, social, and somatic prognostic indicators in old patients undergoing long-term dialysis. Arch Intern Med 147:1921-1924, 1987
  56. *Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira Y, Sunagawa H, Yoshihara K, Yoshi S, Toma S, Kowatari T, Wake T, Oura T, Fukiyama K: Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 51:1212-1217, 1997
  57. Gamba G, Mejia JL, Saldivar S, Pena JC, Correa-Rotter R: Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron 65:23-27, 1993
  58. *Kopple JD, Shinaberger JH, Coburn JW, Sorensen MK, Rubini ME: Evaluating modified protein diets for uremia. J Am Diet Assoc 54:481-485, 1969
  59. *Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw SA, Kopple JD: Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 35:704-711, 1989
  60. *Bergstrom J, Furst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44:1048-1057, 1993
  61. *Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 21:849-861, 1982
  62. Bates CJ, Prentice A, First S: Gender differences in food and nutrient intakes and status indices from the National Diet and Nutrition Survey of people aged 65 years and over. Eur J Clin Nutr 53:694-699, 1999
  63. Peterson S, Sigman-Grant M, Eissenstat B, Kris-Etherton P: Impact of adopting lower-fat food choices on energy and nutrient intake in American adults. J Am Diet Assoc 99:177-183, 1999
  64. Kopple JD, Jones MR, Keshaviah PR, Bergstrom J, Lindsay RM, Moran J, Nolph KD, Teehan BP: A proposed glossary for dialysis kinetics. Am J Kidney Dis 26:963-981, 1995 (editorial)
  65. Fisher H, Brush MK, Griminger P, Sostman ER: Nitrogen retention in adult man: A possible factor in protein requirements. Am J Clin Nutr 20:927-934, 1967
  66. Maroni BJ, Staffeld C, Young VR, Manatunga A, Tom K: Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. J Clin Invest 99:2479-2487, 1997
  67. Kopple JD: Uses and limitations of the balance technique. J Parenter Enteral Nutr 11:S79-S85, 1987 (suppl)
  68. *Panzetta G, Tessitore N, Faccini G, Maschio G: The protein catabolic rate as a measure of protein intake in dialysis patients: Usefulness and limits. Nephrol Dial Transplant 5:S125-S127, 1990 (suppl 1)
  69. *Lorenzo V, de Bonis E, Rufino M, Hernandez D, Rebollo SG, Rodriguez AP, Torres A: Caloric rather than protein deficiency predominates in stable chronic haemodialysis patients. Nephrol Dial Transplant 10:1885-1889, 1995
  70. Chauveau P, Naret C, Puget J, Zins B, Poignet JL: Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: Clinical evaluation of a new on-line urea monitor. Nephrol Dial Transplant 11:1568-1573, 1996
  71. Enia G, Sicuso C, Alati G, Zoccali C: Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8:1094-1098, 1993
  72. *Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J, DiChiro J, Gentile D, Nissenson A, Sakhrani L, Brownjohn AM, Nolph KD, Prowant BF, Algrim CE, Serkes KD: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 17:462-471, 1991
  73. *Kuhlmann MK, Winkelspecht B, Hammers A, Kohler H: [Malnutrition in hemodialysis patients. Self-assessment, medical evaluation and "verifiable" parameters]. Medizinische Klinik 92:13-17, 1997 (in German)
  74. Baker JP, Detsky AS, Wesson DE, Wolman SL, Stewart S, Whitewell J, Langer B, Jeejeebhoy KN: Nutritional assessment: A comparison of clinical judgement and objective measurements. N Engl J Med 306:969-972, 1982
  75. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN: What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 11:8-13, 1987
  76. *Kawaguchi Y, Sugino N, Arai J, Fujii M, Kinoshita Y, Kubo H, Kubo K, Matumoto I, Momose M, Nakamoto M, Nakazato S, Nihei H, Niki A, Nomoto Y, Ono M, Saito A, Sakai S, Shirai D, Takahashi S, Yokoyama K, Chiku T, Yonesh EF, Kopple JD: [Nutritional assessment of patients on continuous ambulatory peritoneal dialysis]. Nippon Jinzo Gakkai Shi Jpn J Nephrol 35:843-851, 1993 (in Japanese)
  77. Hasse J, Strong S, Gorman MA, Liepa G: Subjective global assessment: Alternative nutrition-assessment technique for liver-transplant candidates. Nutrition 9:339-343, 1993
  78. Madill J, Maurer JR, de Hoyos A: A comparison of preoperative and postoperative nutritional states of lung transplant recipients. Transplantation 56:347-350, 1993
  79. Cianciaruso B, Brunori G, Traverso G, Panarello G, Enia G, Strippoli P, De VA, Querques M, Viglino E, Vonesh E, Maiorca R: Nutritional status in the elderly patient with uraemia. Nephrol Dial Transplant 10:S65-S68, 1995 (suppl 6)
  80. Churchill DN, Taylor DW, Keshaviah PR, Thorpe KE, Beecroft ML, Jindal KK, Fenton SSA, Bargman JM, Oreopoulos DG, Wu GG, Lavoie SD, Fine A, Burgess E, Brandes JC, Nolph KD, Prowan BF, Page D, McCusker FX, Teehan BP: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:198-207, 1996
  81. *Woodrow G, Oldroyd B, Smith MA, Turney JH: Measurement of body composition in chronic renal failure: Comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. Eur J Clin Nutr 50:295-301, 1996
  82. De Fijter CW, Oe LP, De Fijter MW, van den Meulen J, Donker AJ, de Vries PM: Is serum albumin a marker for nutritional status in dialysis patients? J Am Soc Nephrol 4:402, 1993
  83. Chumlea WC, Go SS, Vellas B: Assessment of protein-calorie nutrition, in Kopple JD, Massry SG (eds): Nutritional Management of Renal Disease. Baltimore, MD, Williams and Wilkins, 1998, pp 203-228
  84. Heymsfield SB, Tighe A, Wang Z-M: Nutritional assessment by anthropometric and biochemical methods, in Shils ME, Olson JA, Shike M (eds): Modern Nutrition in Health and Disease. Philadelphia, PA, Lea and Febiger, 1984, pp 812-841
  85. Sombolos K, Berkelhammer C, Baker J: Nutritional assessment and skeletal muscle function in patients on continuous ambulatory peritoneal dialysis. Peritoneal Dial Bull 6:53-58, 1986
  86. Kopple JD, Zhu X, Lew NL, Lowrie EG: Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56:1136-1148, 1999
  87. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560-1567, 1999
  88. Fleischmann E, Teal N, Dudley J, Bower J, Salahudeen A: Underweight rather than overweight as the independent predictor for death in hemodialysis. J Am Soc Nephrol 8:208A, 1998 (abstr)
  89. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE: Body weight and mortality among women. N Engl J Med 333:677-685, 1995
  90. Frisancho AR: New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr 40:808-819, 1984
  91. Kushner RF: Body weight and mortality. Nutr Rev 51:127-136, 1993
  92. Rissanen A, Heliovaara M, Knekt P, Aromaa A, Reunanen A, Maatela J: Weight and mortality in Finnish men. J Clin Epidemiol 42:781-789, 1989
  93. Harris T, Cook EF, Garrison R, Higgins M, Kannel W, Goldman L: Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. JAMA 259:1520-1524, 1988
  94. Abraham S, Johnson CL, Najjar F: Weight and height of adults 18-74 years of age. DHEW Pub. No (PHS) 79-1659(211). Washington, DC, US Government Publications Office, Vital and Health Statistics, Series 11, 1979
  95. Najjar MF, Rowland M: Anthropometric reference data and prevalence of overweight, United States, 1976-80. DHHS Pub nr (PHS) 87-1688. Washington, DC, US Government Publications Office, Vital and Health Statistics, Series 11, Nr 238, 1987
  96. Anthropometric data and prevalence of overweight for Hispanics:1982-84. Data from the National Health Survey, 1989. Hyattsville, MD, DHHS, US Government Publications Office, Vital and Health Statistics, Series 11, Nr 239, 1989
  97. Stoudt HW, Damon A, McFarland R: Weight, height, and selected body dimensions of adults. Rockville, MD, US Government Publications Office, DHEW Publications PHS, Vital and Health Statistics, Series 11, Nr 8, 1969
  98. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 272:205-211, 1994
  99. Nelson EE, Hong CD, Pesce AL, Peterson DW, Singh S, Pollak VE: Anthropometric norms for the dialysis population. Am J Kidney Dis 16:32-37, 1990
  100. Kopple JD, Levey AS, Greene T, Chumlea WC, Gassman JJ, Hollinger DL, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS: Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int 52:778-791, 1997
  101. *Formica C, Atkinson MG, Nyulasi I, McKay J, Heale W, Seeman E: Body composition following hemodialysis: Studies using dual-energy X-ray absorptiometry and bioelectrical impedance analysis. Osteoporosis Int 3:192-197, 1993
  102. *Stenver DI, Gotfredsen A, Hilsted J, Nielsen B: Body composition in hemodialysis patients measured by dual-energy X-ray absorptiometry. Am J Nephrol 15:105-110, 1995
  103. *Borovnicar DJ, Wong KC, Kerr PG, Stroud DB, Xiong DW, Strauss BJ, Atkins RC: Total body protein status assessed by different estimates of fat-free mass in adult peritoneal dialysis patients. Eur J Clin Nutr 50:607-616, 1996
  104. Mitch WE, Clark AS: Specificity of the effects of leucine and its metabolites on protein degradation in skeletal muscle. Biochem J 222:579-586, 1984
  105. *Movilli E, Bossini N, Viola BF, Camerini C, Cancarini GC, Feller P, Strada A, Maiorca R: Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. Nephrol Dial Transplant 13:674-678, 1998
  106. Bastani B. McNeely M, Schmitz PG: Serum bicarbonate is an independent determinant of protein catabolic rate in chronic hemodialysis. Am J Nephrol 16:382-285, 1996
  107. Uribarri J: Moderate metabolic acidosis and its effects on nutritional parameters in hemodialysis patients. Clin Nephrol 48:238-240, 1997
  108. Lowrie EG, Zhu X, Lew NL: Primary associates of mortality among dialysis patients: Trends and reassessment of Kt/V and urea reduction ratio as outcome-based measures of dialysis dose. Am J Kidney Dis 32:S16-S31, 1998 (suppl)
  109. Garibotto G, Russo R, Sala MR, Ancarani P, Robaudo C, Sofia A, Deferrari G, Tizianello A: Muscle protein turnover and amino acid metabolism in patients with chronic renal failure. Miner Electrolyte Metab 18:217-221, 1992
  110. *Brady JP, Hasbargen JA: Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Am J Kidney Dis 31:35-40, 1998
  111. Sonikian M, Gogusev J, Zingraff J, Loric S, Quednau B, Bessou G, Siffert W, Drueke TB, Reusch HP, Luft FC: Potential effect of metabolic acidosis on beta 2-microglobulin generation: In vivo and in vitro studies. J Am Soc Nephrol 7:350-356, 1996
  112. Ahmad S, Pagel M, Vizzo J, Scribner BH: Effect of the normalization of acid-base balance on postdialysis plasma bicarbonate. ASAIO Trans 26:318-322, 1980
  113. *Harris DC, Yuill E, Chesher DW: Correcting acidosis in hemodialysis: Effect on phosphate clearance and calcification risk. J Am Soc Nephrol 6:1607-1612, 1995
  114. *Williams AJ, Dittmer ID, McArley A, Clarke J: High bicarbonate dialysate in haemodialysis patients: Effects on acidosis and nutritional status. Nephrol Dial Transplant 12:2633-2637, 1997
  115. Graham KA, Reaich D, Channon SM, Downie S, Gilmour E, Passlick-Deetjen J, Goodship TH: Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 49:1396-1400, 1996
  116. *Barrett BJ, Parfrey PS, Morgan J, Barre P, Fine A, Goldstein MB, Handa SP, Jindal KK, Kjellstrand CM, Levin A, Mandin H, Muirhead N, Richardson RM: Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 29:214-222, 1997
  117. Kooman JP, Deutz NE, Zijlmans P, van dA, Gerlag PG, van HP, Leunissen KM: The influence of bicarbonate supplementation on plasma levels of branched-chain amino acids in haemodialysis patients with metabolic acidosis. Nephrol Dial Transplant 12:2397-2401, 1997
  118. *Stein A, Moorhouse J, Iles-Smith H, Baker F, Johnstone J, James G, Troughton J, Bircher G, Walls J: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52:1089-1095, 1997
  119. Feriani M, Dissegna D, La Greca G, Passlick-Deetjen J: Short-term clinical study with bicarbonate-containing peritoneal dialysis solution. Peritoneal Dial Int 13:296-301, 1993
  120. Lofberg E, Wernerman J, Anderstam B, Bergstrom J: Correction of acidosis in dialysis patients increases branched-chain and total essential amino acid levels in muscle. Clin Nephrol 48:230-237, 1997
  121. *Graham KA, Reaich D, Channon SM, Downie S, Goodship THJ: Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 8:632-637, 1997
  122. Dou L, Brunet P, Dignat-George F, Sampol J, Berland Y: Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin. Am J Kidney Dis 31:67-73, 1998
  123. Lu KC, Shieh SD, Li BL, Chu P, Jan SY, Lin YF: Rapid correction of metabolic acidosis in chronic renal failure: Effect on parathyroid hormone activity. Nephron 67:419-424, 1994
  124. Lin YF, Shieh SD, Diang LK, Lin SH, Chyr SH, Li BL, Lu KC: Influence of rapid correction of metabolic acidosis on serum osteocalcin level in chronic renal failure. ASAIO Journal 40:M440-M444, 1994
  125. *Kang SW, Lee SW, Lee IH, Kim BS, Choi KH, Lee HY, Han DS: Impact of metabolic acidosis on serum albumin and other nutritional parameters in long-term CAPD patients. Adv Perit Dial 13:249-252, 1997
  126. *Dumler F, Galan M: Impact of acidosis on nutritional status in chronic peritoneal dialysis patients. Adv Perit Dial 12:307-310, 1996
  127. Dumler F, Falla P, Butler R, Wagner C, Francisco K: Impact of dialysis modality and acidosis on nutritional status. ASAIO J 45:413-417, 1999
  128. Bray SH, Tung RL, Jones ER: The magnitude of metabolic acidosis is dependent on differences in bicarbonate assays. Am J Kidney Dis 28:700-703, 1996
  129. Thunberg BJ, Swamy AP, Cestero RV: Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 34:2005-2012, 1981
  130. Wolfson M, Strong CJ, Minturn D, Gray DK, Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 39:547-555, 1984
  131. Chazot C, Shahmir E, Matias B, Laidlaw S, Kopple JD: Dialytic nutrition: Provision of amino acids in dialysate during hemodialysis. Kidney Int 52:1663-1670, 1997
  132. Wolfson M, Jones MR, Kopple JD: Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 21:500-506, 1982
  133. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 46:830-837, 1994
  134. Kopple JD, Swendseid ME, Shinaberger JH, Umezawa CY: The free and bound amino acids removed by hemodialysis. ASAIO Trans 19:309-313, 1973
  135. Cheung AK, Agodoa LY, Daugirdas JT, Depner TA, Gotch FA, Greene T, Levin NW, Leypoldt JK: Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol 10:117-127, 1999
  136. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 38:487-494, 1990
  137. Kaplan AA, Halley SE, Lapkin RA, Graeber CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 47:573-578, 1995
  138. Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfsen M, Humphreys MH: Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 14:491-500, 1978
  139. *Ikizler TA, Greene JH, Yenicesu M, Schulman G, Wingard RL, Hakim RM: Nitrogen balance in hospitalized chronic hemodialysis patients. Kidney Int Suppl 57:S53-S56, 1996
  140. *Kopple JD, Shinaberger JH, Coburn JW, Sorensen MK, Rubini ME: Optimal dietary protein treatment during chronic hemodialysis. ASAIO Trans 15:302-308, 1969
  141. *Acchiardo SR, Moore LW, Burk L: Morbidity and mortality in hemodialysis patients. ASAIO Trans 36:M148-M151, 1990
  142. *Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int Suppl 16:S199-S203, 1983
  143. *Movilli E, Mombelloni S, Gaggiotti M, Maiorca R: Effect of age on protein catabolic rate, morbidity, and mortality in uraemic patients with adequate dialysis. Nephrol Dial Transplant 8:735-739, 1993
  144. *Movilli E, Filippini M, Brunori G, Sandrini M, Costantino E, Cristinelli L, Maiorca R: Influence of protein catabolic rate on nutritional status, morbidity and mortality in elderly uraemic patients on chronic haemodialysis: A prospective 3-year follow-up study. Nephrol Dial Transplant 10:514-518, 1995
  145. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW: Protein losses during peritoneal dialysis. Kidney Int 19:593-602, 1981
  146. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 36:395-402, 1982
  147. Wizemann V, Leibinger A, Mueller K, Nilson A: Influence of hydration state on plasma volume changes during ultrafiltration. Artif Organs 19:416-419, 1995
  148. *Pollock CA, Ibels LS, Allen BJ, Ayass W, Caterson RJ, Waugh DA, Macadam C, Pennock Y, Mahony JF: Total body nitrogen as a prognostic marker in maintenance dialysis. J Am Soc Nephrol 6:82-88, 1995
  149. *Giordano C, De Santo G, Pluvio M, Di LA, Capodicasa G, Cirillo D, Esposito R, Damiano M: Protein requirement of patients on CAPD: A study on nitrogen balance. Int J Artif Organs 3:11-14, 1980
  150. Bergstrom J, Heimburger O, Lindholm B: Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 18:467-473, 1998
  151. Kopple JD, Gao XL, Qing DP: Dietary protein, urea nitrogen appearance and total nitrogen appearance in chronic renal failure and CAPD patients. Kidney Int 52:486-494, 1997
  152. Kopple JD, Bernard D, Messana J, Swartz R, Bergstrom J, Lindholm B, Lim V, Brunori G, Leiserowitz M, Bier DM, Stegink L, Martis L, Algrim Boyle C, Serkes K, Vonesh E, Jones M: Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 47:1148-1157, 1995
  153. Jones M, Hagen T, Boyle CA, Vonesh E, Hamburger R, Charytan C, Sandroni S, Bernard D, Piraino B, Schreiber M, Gehr T, Fein P, Friedlander M, Burkart J, Ross D, Zimmerman S, Swartz R, Knight T, Kraus AJ, McDonald L, Hartnett M, Weaver M, Martis L, Moran J: Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: Results of a multicenter outpatient study. Am J Kidney Dis 32:761-769, 1998
  154. Dwyer JT, Cunniff PJ, Maroni BJ, Kopple JD, Burrowes JD, Powers SN, Cockram DB, Chumlea WC, Kusek JW, Makoff R, Goldstein DJ, Paranandi L: The hemodialysis pilot study: Nutrition program and participant characteristics at baseline. The HEMO Study Group. J Ren Nutr 8:11-20, 1998
  155. *Monteon FJ, Laidlaw SA, Shaib JK, Kopple JD: Energy expenditure in patients with chronic renal failure. Kidney Int 30:741-747, 1986
  156. *Schneeweiss B, Graninger W, Stockenhuber F, Druml W, Ferenci P, Eichinger S, Grimm G, Laggner AN, Lenz K: Energy metabolism in acute and chronic renal failure. Am J Clin Nutr 52:596-601, 1990
  157. *Harty J, Conway L, Keegan M, Curwell J, Venning M, Campbell I, Gokal R: Energy metabolism during CAPD: A controlled study. Adv Perit Dial 11:229-233, 1995
  158. *Ikizler TA, Wingard RL, Sun M, Harvell J, Parker RA, Hakim RM: Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol 7:2646-2653, 1996
  159. Food and Nutrition Board NRCN: Recommended Daily Allowances (ed 10). Washington, DC, National Academy Press, 1989
  160. Kopple JD: Dietary protein and energy requirements in ESRD patients. Am J Kidney Dis 32:S97-104, 1998
  161. Caggiula AW, Christakis G, Farrand M, Hulley SB, Johnson R, Lasser NL, Stamler J, Widdowson G: The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids. Prev Med 10:443-475, 1981
  162. Blair SN, Applegate WB, Dunn AL, Ettinger WH, Haskell WL, King AC, Morgan TM, Shih JA, Simons-Morton DG: Activity Counseling Trial (ACT): Rationale, design, and methods. Activity Counseling Trial Research Group. Med Sci Sports Exercise 30:1097-1106, 1998
  163. Gillis BP, Caggiula AW, Chiavacci AT, Coyne T, Doroshenko L, Milas NC, Nowalk MP, Scherch LK: Nutrition intervention program of the Modification of Diet in Renal Disease Study: A self-management approach. J Am Diet Assoc 95:1288-1294, 1995
  164. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WHJ, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA: Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 279:839-846, 1998
  165. Dwyer JT, Kopple JD, Maroni BJ, Burrowes JD, Makoff R, Cunniff PJ, Goldstein DJ, Paranandi L: Dietary intake and nutritional status in the HEMO pilot study population. J Am Soc Nephrol 6:576, 1995
  166. Mitch WE, Maroni BJ: Factors causing malnutrition in patients with chronic uremia. Am J Kidney Dis 33:176-179, 1999
  167. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr 17:S1A-S52A, 1993 (abstr, suppl)
  168. Barton RG: Nutrition support in critical illness. Nutr Clin Pract 9:127-139, 1994
  169. Foulks CJ, Goldstein DJ, Kelly MP, Hunt JM: Indications for the use of intradialytic parenteral nutrition in the malnourished hemodialysis patient. J Ren Nutr 1:23-33, 1991
  170. Kopple JD, Foulks CJ, Piraino B, Beto JA, Goldstein J: Proposed Health Care Financing Administration guidelines for reimbursement of enteral and parenteral nutrition. Am J Kidney Dis 26:995-997, 1995
  171. Geary DF, Chait PG: Tube feeding in infants on peritoneal dialysis. Perit Dial Int 16:S517-S520, 1996 (suppl 1)
  172. Warady BA, Weis L, Johnson L: Nasogastric tube feeding in infants on peritoneal dialysis. Perit Dial Int 16:S521-S525, 1996 (suppl 1)
  173. Kuizon BD, Nelson PA, Salusky IB: Tube feeding in children with end-stage renal disease. Miner Electrolyte Metab 23:306-310, 1997
  174. Cockram DB, Hensley MK, Rodriguez M, Agarwal G, Wennberg A, Ruey P, Ashbach D, Hebert L, Kunau R: Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis. J Ren Nutr 8:25-33, 1998
  175. DeWitt RC, Kudsk KA: Enteral nutrition. Gastroenterol Clin North Am 27:371-386, 1998
  176. Kopple JD: Therapeutic approaches to malnutrition in chronic dialysis patients: The different modalities of nutritional support. Am J Kidney Dis 33:180-185, 1999
  177. *Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG: The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 24:912-920, 1994
  178. Foulks CJ: An evidence-based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis 33:186-192, 1999
  179. Chertow GM: Modality-specific nutrition support in ESRD: Weighing the evidence. Am J Kidney Dis 33:193-197, 1999
  180. Faller B, Aparicio M, Faict D, De Vos C, de Precigout V, Larroumet N, Guiberteau R, Jones M, Peluso F: Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis. Nephrol Dial Transplant 10:1432-1437, 1995
  181. *Misra M, Ashworth J, Reaveley DA, Muller B, Brown EA: Nutritional effects of amino acid dialysate (Nutrineal) in CAPD patients. Adv Perit Dial 12:311-314, 1996
  182. Chertow GM, Lazarus JM, Lyden ME, Caudry D, Nordberg P, Lowrie EG: Laboratory surrogates of nutritional status following administration of intraperitoneal amino acid-based solutions in ambulatory peritoneal dialysis patients. J Ren Nutr 5:116-123, 1995
  183. Bruno M, Bagnis C, Marangella M, Rovera L, Cantaluppi A, Linari F: CAPD with an amino acid dialysis solution: A long-term, cross-over study. Kidney Int 35:1189-1194, 1989
  184. Young GA, Dibble JB, Hobson SM, Tompkins L, Gibson J, Turney JH, Brownjohn AM: The use of an amino-acid-based CAPD fluid over 12 weeks. Nephrol Dial Transplant 4:285-292, 1989
  185. Goodship TH, Lloyd S, McKenzie PW, Earnshaw M, Smeaton I, Bartlett K, Ward MK, Wilkinson R: Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 73:471-478, 1987
  186. Dombros NV, Prutis K, Tong M, Anderson GH, Harrison J, Sombolos K, Digenis G, Pettit J, Oreopoulos DG: Six-month overnight intraperitoneal amino-acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients--No effect on nutritional status. Perit Dial Int 10:79-84, 1990
  187. Jones MR, Gehr TW, Burkart JM, Hamburger RJ, Kraus APJ, Piraino BM, Hagen T, Ogrinc FG, Wolfson M: Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int 18:210-216, 1998
  188. Brulez HF, van Guldener C, Donker AJ, ter Wee PM: The impact of an amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass. Nephrol Dial Transplant 14:154-159, 1999
  189. Vehe KL, Brown RO, Moore LW, Acchiardo SR, Luther RW: The efficacy of nutrition support in infected patients with chronic renal failure. Pharmacotherapy 11:303-307, 1991
  190. *Young GA, Young JB, Young SM, Hobson SM, Hildreth B, Brownjohn AM, Parsons FM: Nutrition and delayed hypersensitivity during continuous ambulatory peritoneal dialysis in relation to peritonitis. Nephron 43:177-186, 1986
  191. *Schilling H, Wu G, Pettit J: Nutritional status of patients on long-term CAPD. Peritoneal Dial Bull 5:12-18, 1985
  192. Lindner A, Tenckhoff H: Nitrogen balance in patients on maintenance peritoneal dialysis. ASAIO Trans 16:255-259, 1970
  193. Chima CS, Meyer L, Hummell AC, Bosworth C, Heyka R, Paganini EP, Werynski A: Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol 3:1516-1521, 1993
  194. Bellomo R, Mansfield D, Rumble S, Shapiro J, Parkin G, Boyce N: A comparison of conventional dialytic therapy and acute continuous hemodiafiltration in the management of acute renal failure in the critically ill. Ren Fail 15:595-602, 1993
  195. Davies SP, Reaveley DA, Brown EA, Kox WJ: Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Crit Care Med 19:1510-1515, 1991
  196. Kopple JD: The nutrition management of the patient with acute renal failure. J Parenter Enteral Nutr 20:3-12, 1996
  197. *Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM: Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386-1391, 1995
  198. *Kopple JD, Berg R, Houser H, Steinman TI, Teschan P: Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl 27:S184-S194, 1989
  199. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS: Relationship between nutritional status and GFR: Results from the MDRD study. Kidney Int 57:1688-1703, 2000
  200. Barrett BJ, Parfrey PS, Morgan J, Barre P, Fine A, Goldstein MB, Handa SP, Jindal KK, Kjellstrand CM, Levin A, Mandin H, Muirhead N, Richardson RM: Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 29:214-222, 1997
  201. *Maggiore Q, Nigrelli S, Ciccarelli C, Grimaldi C, Rossi GA, Michelassi C: Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 50:2103-2108, 1996
  202. *Fenton SS, Johnston N, Delmore T, Detsky AS, Whitewell J, O'Sullivan R, Cattran DC, Richardson RM, Jeejeebhoy KN: Nutritional assessment of continuous ambulatory peritoneal dialysis patients. ASAIO Trans 33:650-653, 1987
  203. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
  204. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, Kusek JW, Rogers NL, Teschan PE: Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 27:652-663, 1996
  205. Levey AS, Greene T, Beck GJ, Caggiula AW, Kusek JW, Hunsicker LG, Klahr S, for the MDRD Study Group: Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown? J Am Soc Nephrol 10:2426-2439, 1999
  206. *Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis. Ann Intern Med 124:627-632, 1996
  207. *Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY: Controlled low protein diets in chronic renal insufficiency: Meta-analysis. BMJ 304:216-220, 1992
  208. Kasiske BL, Lakatua JD, Ma JZ, Louis TA: A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 31:954-961, 1998
  209. Kopple JD, Coburn JW: Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium. Medicine (Baltimore) 52:583-595, 1973
  210. *Walser M: Does prolonged protein restriction preceding dialysis lead to protein malnutrition at the onset of dialysis? Kidney Int 44:1139-1144, 1993
  211. *Tom K, Young VR, Chapman T, Masud T, Akpele L, Maroni BJ: Long-term adaptive responses to dietary protein restriction in chronic renal failure.Am J Physiol 268:E668-E677, 1995
  212. *Kopple JD, Monteon FJ, Shaib JK: Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure. Kidney Int 29:734-742, 1986
  213. *Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, d'Avolio G, Gelatti U: Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 10:2295-2305, 1995
  214. Bonomini V, Feletti C, Scolari MP, Stefoni S: Benefits of early initiation of dialysis. Kidney Int Suppl 17:S57-S59, 1985
  215. Tattersall J, Greenwood R, Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 15:283-289, 1995
  216. McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN: How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl 56:S56-S61, 1995
  217. Lameire NH, Vanholder R, Veyt D, Lambert MC, Ringoir S: A longitudinal, five year survey of urea kinetic parameters in CAPD patients. Kidney Int 42:426-432, 1992
  218. Faller B, Lameire N: Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 9:280-286, 1994
  219. Parker TF III, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM: Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 49:551-556, 1996
  220. Pollock CA, Ibels LS, Zhu FY, Warnant M, Caterson RJ, Waugh DA, Mahony JF: Protein intake in renal disease. J Am Soc Nephrol 8:777-783, 1997
  221. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI: What really happens to people on long-term peritoneal dialysis? Kidney Int 54:2207-2217, 1998
  222. Mailloux LU, Napolitano B, Bellucci AG, Mossey RT, Vernace MA, Wilkes BM: The impact of co-morbid risk factors at the start of dialysis upon the survival of ESRD patients. ASAIO J 42:164-169, 1996
  223. Ifudu O, Dawood M, Homel P, Friedman EA: Timing of initiation of uremia therapy and survival in patients with progressive renal disease. Am J Nephrol 18:193-198, 1998
  224. Brackeen GL, Dover JS, Long CL: Serum albumin. Differences in assay specificity. Nutr Clin Pract 4:203-205, 1989
  225. Doumas BT, Watson WA, Biggs HG: Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31:87-96, 1971
  226. Speicher CE, Widish JR, Gaudot FJ, Hepler BR: An evaluation of the overestimation of serum albumin by bromcresol green. Am J Clin Pathol 69:347-350, 1978
  227. Wells FE, Addison GM, Postlethwaite RJ: Albumin analysis in serum of haemodialysis patients: Discrepancies between bromocresol purple, bromocresol green and electroimmunoassay. Ann Clin Biochem 22:304-309, 1985
  228. Maguire GA, Price CP: Bromcresol purple method for serum albumin gives falsely low values in patients with renal insufficiency. Clin Chim Acta 155:83-87, 1986
  229. Joseph R, Tria L, Mossey RT, Bellucci AG, Mailloux LU, Vernace MA, Miller I, Wilkes BM: Comparison of methods for measuring albumin in peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 27:566-572, 1996
  230. Walser M: Creatinine excretion as a measure of protein nutrition in adults of varying age. J Parenter Enteral Nutr 11:73S-78S, 1987
  231. Mitch WE, Collier VU, Walser M: Creatinine metabolism in chronic renal failure. Clin Sci 58:327-335, 1980
  232. Jones JD, Burnett PC: Creatinine metabolism in humans with decreased renal function: Creatinine deficit. Clin Chem 20:1204-1212, 1974
  233. Keshaviah PR, Nolph KD, Moore HL, Prowant B, Emerson PF, Meyer M, Twardowski ZJ, Khanna R, Ponferrada L, Collins A: Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 4:1475-1485, 1994
  234. Smye SW, Dunderdale E, Brownridge G, Will E: Estimation of treatment dose in high-efficiency haemodialysis. Nephron 67:24-29, 1994
  235. Forbes GB, Bruining GJ: Urinary creatinine excretion and lean body mass. Am J Clin Nutr 29:1359-1366, 1976
  236. Crim MC, Calloway DH, Margen S: Creatine metabolism in men: Urinary creatine and creatinine excretions with creatine feeding. J Nutr 105:428-438, 1975
  237. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S: Measurement of muscle mass in humans: Validity of the 24-hour urinary creatinine method. Am J Clin Nutr 37:478-494, 1983
  238. Buzzard M: 24-hour dietary recall and food record methods, in Willett W (ed): Nutritional Epidemiology. New York, NY, Oxford, 1998, pp 50-73
  239. Gersovitz M, Madden JP, Smiciklas-Wright H: Validity of the 24-hr. dietary recall and seven-day record for group comparisons. J Am Diet Assoc 73:48-55, 1978
  240. Heimburger O, Waniewski J, Werynski A, Lindholm B: A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 41:1320-1332, 1992
  241. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19:564-567, 1981
  242. Health Services, Texas Department of Health, ESRD Facilities, Minumun Standards for Patient Care and Treatment, Provision and Coordination of Treatment and Services. Title 25, Part I, Chapter 117, Subchapter D, Article 117.43, 1996
  243. Kelly MP, Gettel S, Gee C, Meltzer L, Yamaguchi J, Aaron M: Nutritional and demographic data related to the hospitalization of hemodialysis patients. CRN Q 2:16-22, 1987
  244. Sargent JA: Control of dialysis by a single-pool urea model: the National Cooperative Dialysis Study. Kidney Int Suppl 13:S19-S25, 1983
  245. Greene T, Depner T, Daugirdas J: Mathematical coupling and the association between Kt/V and PCRn. Semin Dial 12:S20-S29, 1999
  246. Kloppenburg W, Stegeman C, Vos P, Vastenburg G, Kremer Hovinga T, De Jong P, Huisman R: A high dialysis dose combined with a high protein diet has no beneficial effect on the nutritional status in stable hemodialysis (HD) patients. J Am Soc Nephrol 9:215A-215A, 1998
  247. Cottini EP, Gallina DL, Dominguez JM: Urea excretion in adult humans with varying degrees of kidney malfunction fed milk, egg or an amino acid mixture: Assessment of nitrogen balance. J Nutr 103:11-19, 1973
  248. Grodstein GP, Kopple JD: Urea nitrogen appearance, a simple and practical indicator of total nitrogen output. Kidney Int 16:953A, 1979 (abstr)
  249. Maroni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58-65, 1985
  250. Sargent J, Gotch F, Borah M, Piercy L, Spinozzi N, Schoenfeld P, Humphreys M: Urea kinetics: A guide to nutritional management of renal failure. Am J Clin Nutr 31:1696-1702, 1978
  251. Depner TA, Daugirdas JT: Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 7:780-785, 1996
  252. National Kidney Foundation: NKF-DOQI Clinical Practice Guidelines: Measurement of dialysis adequacy. Am J Kidney Dis 30:S22-S31, 1997 (suppl 2)
  253. National Kidney Foundation: NKF-DOQI Clinical Practice Guidelines: Hemodialysis adequacy III. Blood urea nitrogen (BUN) sampling. Am J Kidney Dis 30:S38-S42, 1997 (suppl 2)
  254. National Kidney Foundation: NKF-DOQI Clinical Practice Guidelines: Hemodialysis adequacy V. Hemodialysis dose troubleshooting. Am J Kidney Dis 30:S46-S48, 1997 (suppl 2)
  255. National Kidney Foundation: NKF-DOQI Clinical Practice Guidelines: Hemodialysis adequacy VII. Appendix B: Kinetic determination of the urea distribution volume. Am J Kidney Dis 30:S58-S63, 1997 (suppl 2)
  256. Depner T, Beck G, Daugirdas J, Kusek J, Eknoyan G: Lessons from the Hemodialysis (HEMO) Study: An improved measure of the actual hemodialysis dose. Am J Kidney Dis 33:142-149, 1999
  257. Randerson DH, Chapman GV, Farrell PC: Amino acids and dietary status in CAPD patients, in Atkins RC, Thomson NM, Farrell PC (eds): Peritoneal Ddialysis. Edinburgh, UK, Churchill Livingstone, 1981, pp 179-191
  258. Keshaviah PR, Nolph KD: Protein catabolic rate calculations in CAPD patients. ASAIO Trans 37:M400-M402, 1991
  259. Chertow GM, Lazarus JM, Lew NL, Ma L, Lowrie EG: Development of a population-specific regression equation to estimate total body water in hemodialysis patients. Kidney Int 51:1578-1582, 1997
  260. Alpers DH, Stenson WF, Bier DM: Obesity, in Alpers DH, Stenson WF, Bier DM (eds): Manual of Nutritional Therapeutics. Boston, MA, 1995
  261. Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97, 1974
  262. *Oe B, De Fijter CWH, Oe PL, Stevens P, De Vries PMJ: Four-site skinfold anthropometry (FSA) versus body impedance analysis (BIA) in assessing nutritional status of patients on maintenance hemodialysis: Which method is to be preferred in routine patient care.Clin Nephrol 49:180-185, 1998
  263. *Schmidt R, Dumler F, Cruz C, Lubkowski T, Kilates C: Improved nutritional follow-up of peritoneal dialysis patients with bioelectrical impedance. Adv Perit Dial 8:157-159, 1992
  264. Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW: Anthropometric measurement of muscle mass: Revised equations for calculating bone-free arm muscle area. Am J Clin Nutr 36:680-690, 1982
  265. *Chertow GM, Jacobs DO, Lazarus JM, Lew NL, Lowrie EG: Phase angle predicts survival in hemodialysis patients. J Ren Nutr 7:204-207, 1997.
  266. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
  267. Walser M: Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 32:23-31, 1998
  268. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
  269. Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995;273:1450-1456 (erratum 274:462, 1995)
  270. Pfeffer MA, Stevenson LW: Beta-adrenergic blockers and survival in heart failure. N Engl J Med 334:1396-1397, 1996 (editorial, comment)
  271. *Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 38:904-911, 1990
  272. Bellinghieri G, Savica V, Barbera CM, Ricciardi B, Egitto M, Torre F, Valentini G, D'Iddio S, Bagiella E, Mallamace A, et al: L-carnitine and platelet aggregation in uremic patients subjected to hemodialysis. Nephron 55:28-32, 1990
  273. *Labonia WD: L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis 26:757-764, 1995
  274. *Rogerson ME, Rylance PB, Wilson R, De Sousa C, Lanigan C, Rose PE, Howard J, Parsons V: Carnitine and weakness in haemodialysis patients. Nephrol Dial Transplant 4:366-371, 1989
  275. *Yderstraede KB, Pedersen FB, Dragsholt C, Trostmann A, Laier E, Larsen HF: The effect of L-carnitine on lipid metabolism in patients on chronic haemodialysis. Nephrol Dial Transplant 1:238-241, 1987
  276. *Nilsson-Ehle P, Cederblad G, Fagher B, Monti M, Thysell H: Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients: Lack of effect of L-carnitine supplementation. Scand J Clin Lab Invest 45:179-184, 1985
  277. *Bellinghieri G, Savica V, Mallamace A, Di Stefano C, Consolo F, Spagnoli LG, Villaschi S, Palmieri G, Corsi M, Maccari F: Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 38:523-531, 1983
  278. *Sohn HJ, Choi GB, Yoon KI: [L-Carnitine in maintenance hemodialysis clinical, lipid and biochemical effects]. Kor J Nephrol 11:260-269, 1992
  279. *Zilleruelo G, Novak M, Hsia SL, Goldberg R, Abitbol C, Monkus E, Strauss J: Effect of dialysate composition on the lipid response to L-carnitine supplementation. Kidney Int Suppl 27:S259-S263, 1989
  280. *Weschler A, Aviram M, Levin M, Better OS, Brook JG: High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis. Nephron 38:120-124, 1984
  281. *Guarnieri GF, Ranieri F, Toigo G, Vasile A, Ciman M, Rizzoli V, Moracchiello M, Campanacci L: Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Am J Clin Nutr 33:1489-1492, 1980
  282. *Caruso U, Cravotto E, Tisone G: Long-term treatment with L-carnitine in uremic patients undergoing chronic hemodialysis: Effects on the lipid pattern. Curr Ther Res Clin Exp 33:1098-1104, 1983
  283. *Casciani CU, Caruso U, Cravotto E, D'Iddio S, Corsi M, Pola P, Savi L, Grilli M: L-carnitine in haemodialysed patients. Changes in lipid pattern. Arzneimittel-Forschung 32:293-297, 1982
  284. *Guarnieri G, Toigo G, Crapesi L, Situlin R, Del Bianco MA, Corsi M, Lo GP, Vasile A: Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis. Kidney Int Suppl 27:S247-S255, 1989
  285. *Wanner C, Wieland H, Wackerle B, Boeckle H, Schollmeyer P, Hörl WH: Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients. Kidney Int Suppl 27:S264-S268, 1989
  286. *Maeda K, Shinzato T, Kobayakawa H: Effects of L-carnitine administration on short-chain fatty acid (acetic acid) and long-chain fatty acid metabolism during hemodialysis. Nephron 51:355-361, 1989
  287. *Mayer G, Graf H, Legenstein E, Linhart L, Auer B, Lohninger A: L-carnitine substitution in patients on chronic hemodialysis. Nephron 52:295-299, 1989
  288. *Vacha GM, Giorcelli G, D'Iddio S, Valentini G, Bagiella E, Procopio A, di Donato S, Ashbrook D, Corsi M: L-carnitine addition to dialysis fluid. A therapeutic alternative for hemodialysis patients. Nephron 51:237-242, 1989
  289. *Lundholm K, Persson H, Wennberg A: Whole body fat oxidation before and after carnitine supplementation in uremic patients on chronic haemodialysis. Clin Physiol 8:417-426, 1988
  290. *Labonia WD, Morelli OJ, Gimenez MI, Freuler PV, Morelli OH: Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int 32:754-759, 1987
  291. *Wanner C, Forstner-Wanner S, Schaeffer G, Schollmeyer P, Horl WH: Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. Am J Nephrol 6:206-211, 1986
  292. *Vacha GM, Giorcelli G, Siliprandi N, Corsi M: Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: Decisive role of low levels of high-density lipoprotein-cholesterol. Am J Clin Nutr 38:532-540, 1983
  293. *Albertazzi A, Capelli P, Di Paola B, Pola P, Tondi P, Vaccario O: Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment. Proc Eur Dial Transplant Assoc 19:302-307, 1983
  294. *Casciani CU, Caruso U, Cravotto E, D'Iddio S, Corsi M, Pola P, Savi L, Grilli M: L-carnitine in haemodialysed patients. Changes in lipid pattern. Arzneimittel-Forschung 32:293-297, 1982
  295. *Wanner C, Wieland H, Nauck M, Schaeffer G, Schollmeyer P, Hörl WH: Effective hypolipidaemic therapy with beclobrate in haemodialysis patients: Interference with L-carnitine. Nephrol Dial Transplant 5:588-593, 1990
  296. *Srivastava DK, Kumar S, Misra AP: Reversal of haemodialysis induced hypertriacylglycerolemia by L-carnitine. Indian J Clin Biochem 7:19-21, 1992
  297. *Galeone F, Giacomelli A, Rossi A, Giuntoli F, Micheli C, Saba P: L-carnitine activity on serum lipid patterns in chronic uraemia. A study of patients on dialysis. Clin Trials J 24:417-424, 1987
  298. *Huissoon AP, Meehan S, Brian KJ: Carnitine replacement and maintenance by addition of L-carnitine to dialysis fluid. J Nephrol 6:103-107, 1993
  299. *Mioli V, Tarchini R, Boggi R: Use of D,L- and L-carnitine in uraemic patients on intermittent haemodialysis. Int J Clin Pharmacol Res 2:143-148, 1982
  300. *Dionisio P, Bergia R, Caramello E, Graziola M, Valenti M, Bajardi P, Barbera L, Voglino F: [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients]. Minerva Medica 76:229-234, 1985 (in Italian)
  301. *Fujita Y, Shinzato T, Takai I, Kobayakawa H, Ozawa Y, Maeda K: Efficacy of L-carnitine administration for long-term dialysis patients with continuous hypotension. Jpn J Artific Organs 17:132-135, 1988 (in Japanese)
  302. *Trivelli G, Vitali P, Girmenia S, Castelli F: Treatment of serum lipid abnormalities in hemodialysed patients with carnitine. (Original: Trattamento della dislipidemia dell'emodializzato con l-carnitina.) Clin Eur 22:405-415, 1983
  303. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 54:1720-1725, 1998
  304. *van Es A, Henny FC, Kooistra MP, Lobatto S, Scholte HR: Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis. Contri Nephrol 98:28-35, 1992
  305. *Fagher B, Cederblad G, Monti M, Olsson L, Rasmussen B, Thysell H: Carnitine and left ventricular function in haemodialysis patients. Scand J Clin Lab Invest 45:193-198, 1985
  306. Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38:912-918, 1990
  307. Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, Nakai S, Miwa M, Morita H, Miwa T, Amano I, Maeda K: Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients. Am J Kidney Dis 32:258-264, 1998
  308. Casciani CU, Caruso U, Cravotto E: Beneficial effects of L-carnitine in post dialysis syndrome. Curr Therap Res Clin Exp 32:116-127, 1982
  309. *Fagher B, Cederblad G, Eriksson M, Monti M, Moritz U, Nilsson-Ehle P, Thysell H: L-carnitine and haemodialysis: Double blind study on muscle function and metabolism and peripheral nerve function. Scand J Clin Lab Invest 45:169-178, 1985
  310. Sloan RS, Kastan B, Rice SI, Sallee CW, Yuenger NJ, Smith B, Ward RA, Brier ME, Golper TA: Quality of life during and between hemodialysis treatments: Role of L-carnitine supplementation. Am J Kidney Dis 32:265-272, 1998
  311. *Siami G, Clinton ME, Mrak R, Griffis J, Stone W: Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis. Nephron 57:306-313, 1991
  312. Albertazzi A, Spisni C, Del Rosso G, Palmieri PF, Rossini PM: Electromyographic changes induced by oral carnitine treatment in dialysis patients. Proc Clin Dial Transplant Forum 10:1-6, 1980
  313. Kooistra MP, Struyvenberg A, van Es A: The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels. Nephron 57:127-128, 1991
  314. *Thompson CH, Irish AB, Kemp GJ, Taylor DJ, Radda GK: The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure. Clin Nephrol 47:372-378, 1997
  315. *Donatelli M, Terrizzi C, Zummo G, Russo V, Bucalo ML, Scarpinato A: Effects of L-carnitine on chronic anemia and erythrocyte adenosine triphosphate concentration in hemodialyzed patients. Curr Ther Res 41:620-624, 1987
  316. *Trovato GM, Ginardi V, Di Marco V, Dell'Aira AE, Corsi M: Long term L-carnitine treatment of chronic anaemia of patients with end stage renal failure. Curr Ther Res 31:1042-1049, 1982
  317. *Caruso U, Leone L, Cravotto E, Nava D: Effects of L-carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin: A pilot study. Dial Transplant 27:498-506, 1998
  318. Bishop CW, Bowen PE, Ritchey SJ: Norms for nutritional assessment of American adults for upper arm anthropometry. Am J Clin Nutr 34:2530-2539, 1981
 

Back to top | Main Page

© 2000 National Kidney Foundation, Inc.

Web version created by cyberNephrologyTM and The Nephron Information Center